US-based SpringWorks Therapeutics, which specialises on developing medicines and treatments for cancers and severe rare diseases, has raised $125m in a series B funding round led by Perceptive Advisors.
At the end of a successful Pulmonary Hypertension Awareness Month, members of the Pulmonary Hypertension Association of Canada (PHA Canada) and Scleroderma Canada (SC) have come together to thank provincial governments for providing the majority of Canadi